Related Experiment Videos
Circulatory and metabolic aspects of beta-adrenoceptor blockade
1Albert Einstein College of Medicine, Albert Einstein Hospital, Bronx, NY 10461.
Insights
Beta-blocking agents are widely used for various conditions, including hypertension and heart disease. Careful drug selection is crucial to optimize benefits and minimize risks like bronchoconstriction and altered glucose metabolism.
Area of Science:
- Pharmacology
- Cardiology
- Internal Medicine
Background:
- Beta-blocking agents are a cornerstone therapy for numerous cardiovascular and non-cardiovascular conditions.
- Their diverse applications range from hypertension and angina to arrhythmias and glaucoma.
Purpose of the Study:
- To review the broad therapeutic applications of beta-blockers.
- To elucidate the pharmacodynamic effects and potential adverse events associated with beta-blockade.
- To emphasize the importance of individualized drug selection based on patient profiles.
Main Methods:
- Literature review of studies on beta-blocker pharmacology and clinical use.
- Analysis of pharmacodynamic effects on cardiac conduction, respiratory function, and metabolic processes.
- Evaluation of drug profiles, including selectivity and partial agonist activity.
Main Results:
- Beta-blockers beneficially affect sinus node and atrioventricular conduction but high doses can cause block.
- Nonselective agents may worsen bronchoconstriction in asthmatics; selective or partial agonist drugs are better tolerated.
- Hypoglycemia can be prolonged, with selective agents showing less metabolic interference.
Conclusions:
- Beta-blockade influences various physiological systems, including lipids, thyroid hormones, and platelet aggregation.
- Drug choice requires understanding pharmacodynamic/pharmacokinetic profiles and patient-specific conditions.
- Personalized selection ensures optimal therapeutic outcomes and minimizes adverse effects.
Abstract:
beta-Blocking therapy is used extensively is conditions as diverse as hypertension, angina pectoris, arrhythmias, thyrotoxicosis, hypertrophic cardiomyopathy, migraine, glaucoma, and myocardial infarction. Studies show they beneficially influence sinus node and atrioventricular conduction, but excessively high doses may cause sinus arrest or sinoatrial block. Nonselective beta-blockade in asthmatic patients may aggravate bronchoconstriction, whereas increased airways resistance is less likely with beta 1-selective, partial agonist, or alpha-beta-blocking drugs. Hypoglycemia can be prolonged; beta 1-selective or partial agonist drugs may cause less interference with glucose metabolism. beta-Blockade affects free fatty acids, lipids and lipoproteins, thyroid hormones, and parathormone. beta-Blockade may normalize abnormal platelet aggregation. Finally, the choice of the most effective drug depends on the clinician's knowledge of the various pharmacodynamic and pharmacokinetic drug profiles, allied with familiarity of the patient's medical condition.